Ruoyu Yao
Guofen Xu1
Han Wang
Yu Chen
Jia Yao
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Department of Gastroenterology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China
- 2Fourth Department of Liver Disease (Difficult and Complicated Liver Diseases and Artificial Liver Center), Beijing You’an Hospital Affiliated to Capital Medical University, Beijing, China
By Yao R, Xu G, Fu X, Zhang W, Wang H, Chen Y and Yao J (2025) Front. Cell. Infect. Microbiol. 14:1471974. doi: 10.3389/fcimb.2024.1471974
In the published article, there was an error in Figures 3 and 4 as published. The images for Figures 3 and 4 were swapped in order. The corrected Figures 3 and 4 and their captions appear below.
Figure 3
Figure 3. MELD-Na scores of patients in the ACLF, ACLF+COVID-19, and COVID-19 groups one week after admission.
Figure 4
Figure 4. The 28-day survival curves of ACLF, ACLF+COVID-19, and COVID- 19 groups.
In the published article, there was an error in Table 1 as published. The category headings for indicators were omitted in Table 1. The corrected Table 1 and its caption appear below.
Table 1
Table 1. Basic features of patients in the three groups at admission.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: acute-on-chronic liver failure, COVID-19, SARS-CoV-2, mortality, prognosis, IL-6
Citation: Yao R, Xu G, Fu X, Zhang W, Wang H, Chen Y and Yao J (2025) Corrigendum: Clinical characteristics and the role of IL-6 in acute-on-chronic liver failure patients with or without COVID-19: a multicenter paired cohort study. Front. Cell. Infect. Microbiol. 15:1584105. doi: 10.3389/fcimb.2025.1584105
Received: 26 February 2025; Accepted: 27 February 2025;
Published: 12 March 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Yao, Xu, Fu, Zhang, Wang, Chen and Yao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jia Yao, eWFvamlhMjAwNkAxNjMuY29t; Yu Chen, Y2h5YmV5b25kMTA3MUBjY211LmVkdS5jbg==